Vision-Sciences to Present at Lazard Capital Markets 9th Annual Healthcare Conference
ORANGEBURG, N.Y., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced the Company will present at the Lazard Capital Markets 9th Annual Healthcare Conference to be held at the Pierre Hotel in New York City on November 13th and 14th.
Cynthia Ansari, President and Chief Executive Officer, will present on Tuesday, November 13, 2012 at 11:30 a.m. Eastern Standard Time. The presentation will also be available via a live audio webcast at the following link: http://wsw.com/webcast/lz13/vsci/.
Following the presentation, a replay will be available through the Company's website at www.visionsciences.com under the
"Investors" section and will remain available for two weeks after the actual presentation date.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for endoscopy - the science of using an instrument, known as an endoscope, to provide minimally invasive access to areas not readily available to the human eye. Vision-Sciences' unique flexible endoscopic products utilize a streamlined visualization system and proprietary sterile disposable sheaths, known as EndoSheath technology, to provide users quick, efficient endoscope turnover while ensuring enhanced patient safety through the use of sterile, single-use technology. Within its medical segment, Visio-nSciences targets five main areas for its fiber and video endoscopes and EndoSheath technology: urology, pulmonology, gastroenterology (GI), ENT (ear, nose and throat) and spine. Information about Visio-nSciences' products is available at www.visionsciences.com.
Vision Sciences®, Slide-On®, EndoSheath®, EndoWipe® and The Vision System®are registered trademarks of Vision- Sciences, Inc.
The Vision-Sciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3876
CONTACT: Keith Darragh
VP, Finance and Principal Financial and Accounting Officer